TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33319866

Group type: EXPERIMENTAL
Intervention: Ramelteon (0.1 mg kg-1 dissolved in 5 mL of lactose-containing syrup)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (same amount of syrup alone)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ramelteon
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 34145479

Group type: EXPERIMENTAL
Intervention: SRP + PE
Number of subjects: 37

Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 37
Study: 34306265

Group type: EXPERIMENTAL
Intervention: LABA + inhaled corticosteroid (formoterol/budesonide)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: LAMA + inhaled corticosteroid (tiotropium/budesonide)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: LABA + LAMA (formoterol/tiotropium)
Number of subjects: 45
Study: 35032204

Group type: EXPERIMENTAL
Intervention: Gastrotuss® (20 ml, three daily doses)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Omeprazole (20 mg, once daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Comparison between Gastrotuss® and Omeprazole
Number of subjects: 50
Study: 32045879

Group type: EXPERIMENTAL
Intervention: Hydrogen-rich water (HRW)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 34060968

Group type: EXPERIMENTAL
Intervention: Home-based pulmonary rehabilitation
Number of subjects: 141

Group type: COMPARATOR
Intervention: Center-based pulmonary rehabilitation
Number of subjects: 141
Study: 32613311

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation with targeted intensity
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (standard rehabilitation)
Number of subjects: 34
Study: 34455728

Group type: EXPERIMENTAL
Intervention: Aromatherapy with rose essential oil (REO), 3 drops by inhalation, three times a day for 3 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo, 3 drops by inhalation, three times a day for 3 days
Number of subjects: 80
Study: 32249917

Group type: EXPERIMENTAL
Intervention: Detection of malaria pigment by histopathology in ≥30% of high-powered fields
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Detection of malaria parasites by microscopy or LAMP
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Presence of malaria pigment detected by histopathology
Number of subjects: 637
Study: 32927487

Group type: EXPERIMENTAL
Intervention: Calcitriol (0.25 μg pills, 2 pills daily for 4 weeks)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 32023234

Group type: EXPERIMENTAL
Intervention: Circumferential patellar cauterization
Number of subjects: 78

Group type: COMPARATOR
Intervention: Non-cauterized patella
Number of subjects: 78
Study: 34542399

Group type: EXPERIMENTAL
Intervention: Acceptance and commitment therapy (ACT)
Number of subjects: 37
Study: 32482534

Group type: EXPERIMENTAL
Intervention: Adjuvant mFOLFOX6 (oxaliplatin 85 mg/m², leucovorin 400 mg/m², and 5‐FU bolus 400 mg/m² then 5FU Continuous infusion 2.4 g/m²) every two weeks for 12 cycles
Number of subjects: 198

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Adjuvant mFOLFOX6
Number of subjects: 198
Study: 33864109

Group type: EXPERIMENTAL
Intervention: Olfactory training (OT) performed twice a day
Number of subjects: 55

Group type: COMPARATOR
Intervention: Olfactory training (OT) performed four times a day
Number of subjects: 55
Study: 34360168

Group type: EXPERIMENTAL
Intervention: ChroPreg intervention
Number of subjects: 362

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 362
Study: 32375440

Group type: EXPERIMENTAL
Intervention: Phentolamine
Number of subjects: 62
Study: 33733897

Group type: EXPERIMENTAL
Intervention: Incremental approach
Number of subjects: 790

Group type: COMPARATOR
Intervention: Standard approach
Number of subjects: 790
Study: 32969384

Group type: EXPERIMENTAL
Intervention: Infusion therapy (furosemide infusion at 2mg/hour and albumin at 2g/hour for three days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Bolus therapy (intravenous albumin and furosemide as boluses)
Number of subjects: 30
Study: 34424102

Group type: EXPERIMENTAL
Intervention: Stimulus control techniques (antecedent-based condition - AC)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Contingency management techniques (consequent-based condition - CC)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Waitlist (control group)
Number of subjects: 92
Study: 32891678

Group type: EXPERIMENTAL
Intervention: Shared decision-making (SDM) with patient decision aids (PDAs)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Non-shared decision-making (non-SDM)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Shared decision-making (SDM) with PDAs
Number of subjects: 180
Study: 35687528

Group type: EXPERIMENTAL
Intervention: Delamanid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bedaquiline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delamanid + Bedaquiline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 34474038

Group type: EXPERIMENTAL
Intervention: PTG-100 (150, 300, or 900 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34176104

Group type: EXPERIMENTAL
Intervention: Technology-based information and coaching/support program
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 99
Study: 34256993

Group type: EXPERIMENTAL
Intervention: Conditional Cash Transfers (CCT)
Number of subjects: 880
Study: 36345870

Group type: EXPERIMENTAL
Intervention: Preoperative colonoscopy combined with right gastroepiploic vein preservation (RGV preserved during operation)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (RGV not preserved during operation)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study: 33749997

Group type: EXPERIMENTAL
Intervention: Diclofenac-Hyaluronate Conjugate (DF-HA) 30 mg, administered via intraarticular injection once every 4 weeks for 20 weeks (total of 6 injections)
Number of subjects: 440

Group type: COMPARATOR
Intervention: Placebo (citric acid-sodium citrate buffered solution), administered via intraarticular injection once every 4 weeks for 20 weeks (total of 6 injections)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Diclofenac-Hyaluronate Conjugate (DF-HA)
Number of subjects: 440
Study: 32593960

Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training (RAGT)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Conventional overground therapy (CT)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: All P‐MS
Number of subjects: 61
Study: 34400361

Group type: EXPERIMENTAL
Intervention: Prone positioning
Number of subjects: 0
Study: 35894865

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 266

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 266
Study: 34075821

Group type: EXPERIMENTAL
Intervention: EG6s (eccentric contraction runtime = 6 seconds)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: EG3s (eccentric contraction runtime = 3 seconds)
Number of subjects: 36
Study: 35101041

Group type: EXPERIMENTAL
Intervention: Interactive online education program for communication skills related to anxiety and depression screening and referral.
Number of subjects: 20
Study: 33930610

Group type: EXPERIMENTAL
Intervention: Closeness-generating conversation
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Small talk conversation
Number of subjects: 118
Study: 36085255

Group type: EXPERIMENTAL
Intervention: Educational videos
Number of subjects: 220

Group type: COMPARATOR
Intervention: Digital version of the maternal and child health handbook
Number of subjects: 220
Study: 32406579

Group type: EXPERIMENTAL
Intervention: Macitentan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 0
Study: 35281951

Group type: EXPERIMENTAL
Intervention: Watson care theory nursing and eye muscle suture with absorbable sutures
Number of subjects: 148

Group type: COMPARATOR
Intervention: Routine nursing (Control)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Watson care theory nursing
Number of subjects: 148
Study: 34169541

Group type: EXPERIMENTAL
Intervention: Cold temperature (CT) leukofiltration
Number of subjects: 6894

Group type: COMPARATOR
Intervention: Room temperature (RT) leukofiltration
Number of subjects: 6894
Study: 32912051

Group type: EXPERIMENTAL
Intervention: SystemCHANGE™ + Activity Tracker
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control
Number of subjects: 53
Study: 34292451

Group type: EXPERIMENTAL
Intervention: Pazopanib (median dose 150 mg daily for a median of 22 months)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Pazopanib
Number of subjects: 13
Study: 33514577

Group type: EXPERIMENTAL
Intervention: Manubrium‐limited mini‐sternotomy
Number of subjects: 270

Group type: COMPARATOR
Intervention: Conventional median sternotomy
Number of subjects: 270
Study: 34047133

Group type: EXPERIMENTAL
Intervention: Child Compound Endothelium Corneum (CCEC)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Erpixing Granules
Number of subjects: 240
Study: 33755182

Group type: EXPERIMENTAL
Intervention: Mortality threat (MT)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Neutral control (NC)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Machine-learning approach
Number of subjects: 86
Study: 35597057

Group type: EXPERIMENTAL
Intervention: Supervised group (pelvic floor muscle training and yoga)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Unsupervised group (pelvic floor muscle training and yoga)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Supervised group
Number of subjects: 91

Group type: COMPARATOR
Intervention: Unsupervised group
Number of subjects: 91
Study: 33558250

Group type: EXPERIMENTAL
Intervention: Paediatric drug RCTs published in 2017-2018
Number of subjects: 100
Study: 32784188

Group type: EXPERIMENTAL
Intervention: Fatigue in Teenagers on the InterNET, a web-based modular CFS/ME-specific cognitive behavioral therapy program supported by individualized clinical psychologist electronic consultations.
Number of subjects: 89

Group type: COMPARATOR
Intervention: Skype-delivered activity management with a CFS/ME clinician (physiotherapist or occupational therapist).
Number of subjects: 89
Study: 35909257

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 358
Study: 33634851

Group type: EXPERIMENTAL
Intervention: Antiepileptic drugs (AEDs)
Number of subjects: 78615

Group type: EXPERIMENTAL
Intervention: HDACi AEDs
Number of subjects: 78615

Group type: COMPARATOR
Intervention: Other AEDs
Number of subjects: 78615
Study: 35130934

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Theater-Based Intervention (TBI)
Number of subjects: 68
Study: 34464411

Group type: EXPERIMENTAL
Intervention: Virtual reality (VR) using a dome screen during IV placement
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no VR) during IV placement
Number of subjects: 19

Group type: COMPARATOR
Intervention: Guardian's satisfaction and rating of child's distress
Number of subjects: 19
Study: 32767989

Group type: EXPERIMENTAL
Intervention: Video consultations with a physiotherapist
Number of subjects: 394

Group type: COMPARATOR
Intervention: Face-to-face consultations with a physiotherapist
Number of subjects: 394
Study: 35565740

Group type: EXPERIMENTAL
Intervention: Low Glycemic Index Mediterranean Diet (LGIMD)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Aerobic activity program (ATFIS_1)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Combined activity program (ATFIS_2)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: LGIMD plus ATFIS_1 or ATFIS_2
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control Diet based on CREA‐AN (INRAN)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: LGIMD-ATFIS_1 group
Number of subjects: 109
Study: 34551955

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (standard of care plus Mediterranean diet)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard of care for constipation (control)
Number of subjects: 52
Study: 35256515

Group type: EXPERIMENTAL
Intervention: Durvalumab after chemoradiotherapy (CRT)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Durvalumab after CRT
Number of subjects: 133

Group type: COMPARATOR
Intervention: CRT alone
Number of subjects: 133
Study: 33113295

Group type: EXPERIMENTAL
Intervention: LY-CoV555 2800 mg
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: LY-CoV555 700 mg
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: LY-CoV555 7000 mg
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: LY-CoV555 (all doses combined)
Number of subjects: 452

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 452
Study: 36394295

Group type: EXPERIMENTAL
Intervention: Interactive web-based self-management system for hypertension (daily measurement of BP and pulse, reports of well-being, symptoms, lifestyle, medication intake, side effects, reminders, motivational messages) for 8 weeks
Number of subjects: 949

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 949

Group type: EXPERIMENTAL
Intervention: Interactive web-based self-management system for hypertension
Number of subjects: 949
Study: 35350097

Group type: COMPARATOR
Intervention: Dexamethasone (DEX)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Tocilizumab plus Dexamethasone (TCZ+DEX)
Number of subjects: 450
Study: 32469414

Group type: EXPERIMENTAL
Intervention: Bone Marrow Transplant (BMT)
Number of subjects: 107
Study: 36049674

Group type: EXPERIMENTAL
Intervention: Digital asthma self-management (DASM) program
Number of subjects: 900

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 900
Study: 33549381

Group type: EXPERIMENTAL
Intervention: PRICE therapy (protection, rest, ice (cryotherapy at 3°C), compression (35 mm Hg), elevation)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 33070332

Group type: EXPERIMENTAL
Intervention: Biosimilar infliximab (CT‐P13, Inflectra)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Originator infliximab (Remicade)
Number of subjects: 345
Study: 34479822

Group type: EXPERIMENTAL
Intervention: TOPP-Trauma
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (educational pamphlet)
Number of subjects: 50
Study: 33522094

Group type: EXPERIMENTAL
Intervention: PCOS group
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: QUICK‐I
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (age and BMI matched)
Number of subjects: 180
Study: 32828721

Group type: EXPERIMENTAL
Intervention: Cognitive stress
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Emotional stress
Number of subjects: 25

Group type: COMPARATOR
Intervention: No stress
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Dorsolateral prefrontal cortex activity
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Ventral striatum activity
Number of subjects: 25
Study: 35850007

Group type: EXPERIMENTAL
Intervention: Self-compassion induction (guided self-compassion writing task)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control condition (writing task to review the stress test)
Number of subjects: 67
Study: 33974448

Group type: EXPERIMENTAL
Intervention: Computer-based noise desensitization training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 20
Study: 32586400

Group type: EXPERIMENTAL
Intervention: Health intervention (CHAMPION2)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Education intervention (STRIPES2)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Usual health services (control for STRIPES2)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Usual education services (control for CHAMPION2)
Number of subjects: 196
Study: 35752581

Group type: EXPERIMENTAL
Intervention: Reiki
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Hand massage
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control
Number of subjects: 105
Study: 36123109

Group type: EXPERIMENTAL
Intervention: 15 one-way educative and reminder text messages
Number of subjects: 115
Study: 32646379

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 130
Study: 32285720

Group type: EXPERIMENTAL
Intervention: Yoga programs during incarceration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matched control group (no yoga participation)
Number of subjects: 0
Study: 33976542

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (no TEAS)
Number of subjects: 100
Study: 34615860

Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 (AZD1222) vaccine
Number of subjects: 153
Study: 32504314

Group type: EXPERIMENTAL
Intervention: Bezlotoxumab (10 mg/kg single intravenous infusion)
Number of subjects: 606

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 606
Study: 35379484

Group type: EXPERIMENTAL
Intervention: Video-modelling (VM)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Remote telementoring (RTM)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study: 33657679

Group type: EXPERIMENTAL
Intervention: Melatonin (2 mg per day at night)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 164
Study: 36921619

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Chinese herbal medicine (CHM)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Acupuncture combined with CHM placebo
Number of subjects: 95

Group type: COMPARATOR
Intervention: CHM combined with sham acupuncture
Number of subjects: 95
Study: 33780573

Group type: EXPERIMENTAL
Intervention: CC-486 as maintenance therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Venetoclax and azacitidine combination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Any therapy
Number of subjects: 0
Study: 35001513

Group type: EXPERIMENTAL
Intervention: three good things intervention
Number of subjects: 267

Group type: COMPARATOR
Intervention: early memories (placebo control)
Number of subjects: 267
Study: 33622382

Group type: EXPERIMENTAL
Intervention: Probiotics (840 mg bid) plus dietary fiber (30 g bid)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Probiotics (840 mg bid) plus placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Placebo plus dietary fiber (30 g bid)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 100
Study: 35338764

Group type: EXPERIMENTAL
Intervention: I gel
Number of subjects: 90

Group type: COMPARATOR
Intervention: Ambu Auragain
Number of subjects: 90

Group type: COMPARATOR
Intervention: All devices
Number of subjects: 90
Study: 33530713

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation intervention
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 110
Study: 35834762

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy followed by autologous stem-cell transplantation (ASCT)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Whole-brain radiotherapy (WBRT)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 97
Study: 34372561

Group type: EXPERIMENTAL
Intervention: nOPV2 candidates
Number of subjects: 49
Study: 35439775

Group type: EXPERIMENTAL
Intervention: Blepharoexfoliation with tea tree oil 2% shampoo followed by eyelid scrubs with tea tree oil 2% shampoo twice a day for 8 weeks
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group with sham blepharoexfoliation and eyelid scrubs with tea tree oil 2% shampoo twice a day for 8 weeks
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Blepharoexfoliation group
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 81
Study: 33440080

Group type: EXPERIMENTAL
Intervention: Fotagliptin (24 mg, once-daily for 14 days)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (once-daily for 14 days)
Number of subjects: 14
Study: 33302666

Group type: EXPERIMENTAL
Intervention: Permissive hypercapnia (PHC) ventilation strategy, maintaining PaCO2 at 46-60 mmHg.
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Permissive hypercapnia (PHC) ventilation strategy.
Number of subjects: 66

Group type: COMPARATOR
Intervention: Conventional ventilation (Group C).
Number of subjects: 66
Study: 35099523

Group type: EXPERIMENTAL
Intervention: Multicomponent vaccine campaign
Number of subjects: 7496

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 7496
Study: 33299880

Group type: EXPERIMENTAL
Intervention: High C-reactive protein-to-albumin ratio (CAR)
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: Nomogram prediction model
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: Calibration curve
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: CAR, CEA, lymph node metastasis, operation mode, perineural invasion
Number of subjects: 676
Study: 34580419

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 32070905

Group type: EXPERIMENTAL
Intervention: Implicit tax (20% higher post-tax prices)
Number of subjects: 941

Group type: EXPERIMENTAL
Intervention: Fake tax (pre-tax prices with a false 20% tax label)
Number of subjects: 941

Group type: EXPERIMENTAL
Intervention: Explicit tax (actual 20% price increase with a false tax label)
Number of subjects: 941

Group type: COMPARATOR
Intervention: Control (no tax)
Number of subjects: 941
Study: 35575751

Group type: EXPERIMENTAL
Intervention: Closed-loop therapy (MiniMed 670G)
Number of subjects: 0
Study: 34410322

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) - 12 weeks, thrice-weekly, supervised aerobic sessions at 85% to 95% of peak oxygen consumption (V̇o2)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 52
Study: 32271150

Group type: EXPERIMENTAL
Intervention: eHealth intervention for weekly monitoring of side effects using PRO-CTCAE questions
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: eHealth intervention for weekly monitoring of side effects
Number of subjects: 57
Study: 34341833

Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 179

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 179